# FDA Inspection 1255316 - Texas Children's Hospital The Woodlands - November 13, 2024

Source: https://www.keypedia.com/records/fda_inspections/texas-childrens-hospital-the-woodlands/cb77e7ec-4d53-45c9-820d-2efc1087b260
Source feed: FDA_Inspections

> FDA Inspection 1255316 for Texas Children's Hospital The Woodlands on November 13, 2024. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1255316
- Company Name: Texas Children's Hospital The Woodlands
- Inspection Date: 2024-11-13
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1255316 - 2024-11-13](https://www.keypedia.com/records/fda_inspections/texas-childrens-hospital-the-woodlands/c562e2d4-1a7a-43f8-8ece-50bff10c98de)
- [FDA Inspection 1092126 - 2019-04-24](https://www.keypedia.com/records/fda_inspections/texas-childrens-hospital-the-woodlands/e5929f4a-70c8-426b-90c9-28b5cd475a89)

Company: https://www.keypedia.com/companies/texas-childrens-hospital-the-woodlands/48486f57-2071-4715-9263-7e7bbf71d8ac

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d